Medivolve Past Earnings Performance

Past criteria checks 0/6

Medivolve's earnings have been declining at an average annual rate of -9%, while the Healthcare industry saw earnings growing at 5.6% annually. Revenues have been growing at an average rate of 38.4% per year.

Key information

-9.0%

Earnings growth rate

17.4%

EPS growth rate

Healthcare Industry Growth8.5%
Revenue growth rate38.4%
Return on equityn/a
Net Margin-539.5%
Last Earnings Update31 Dec 2023

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Medivolve makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:MEDV.F Revenue, expenses and earnings (CAD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 231-440
30 Sep 2337-9260
30 Jun 2337-10260
31 Mar 2322-20300
31 Dec 221-15140
30 Sep 2248-7190
30 Jun 22732210
31 Mar 22922240
31 Dec 2187-7260
30 Sep 2151-39280
30 Jun 2126-48260
31 Mar 2122-46240
31 Dec 2011-38140
30 Sep 200-1160
30 Jun 200-1050
31 Mar 200-430
31 Dec 190-320
30 Sep 190-220
30 Jun 190-220
31 Mar 190-110
31 Dec 180-110
30 Sep 180440
30 Jun 180440
31 Mar 180340
31 Dec 170340
30 Sep 170-220
30 Jun 170-110
31 Mar 170-110
31 Dec 160-110
30 Sep 160000
30 Jun 160-110
31 Mar 160-110
31 Dec 150-110
30 Sep 150-110
30 Jun 150-110
31 Mar 150-220
31 Dec 140-220
30 Sep 140-220
30 Jun 140-320
31 Mar 140-220
31 Dec 130-220
30 Sep 130-210

Quality Earnings: MEDV.F is currently unprofitable.

Growing Profit Margin: MEDV.F is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: MEDV.F is unprofitable, and losses have increased over the past 5 years at a rate of 9% per year.

Accelerating Growth: Unable to compare MEDV.F's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MEDV.F is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (12.5%).


Return on Equity

High ROE: MEDV.F's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.